Notice of Intent to Sole Source – Cardinal Health, Inc.
Closed Special Notice Posted
- Solicitation number
- 24-006053
- Agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- Q509 Family & Internal Medicine Services
- Place of performance
- Bethesda, Maryland, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health (NIH) Clinical Center has published a Special Notice expressing its intent to award a sole source, fixed-price purchase order to Cardinal Health, Inc. to provide 10 vials of Floxuridine for injection. This acquisition will be conducted using the simplified acquisition procedures outlined in Federal Acquisition Regulation (FAR) Part 13.
The purpose of this Special Notice is to notify interested parties of the NIH's intent to purchase the required Floxuridine for injection from Cardinal Health, Inc., the sole distributor of this product in the United States. The due date for submitting comments or identifying capabilities in response to this notice is April 25, 2024. This acquisition is exempt from the competition requirements of FAR Part 6, as it is being conducted using the simplified acquisition procedures outlined in FAR Part 13, which allow for sole-source awards under certain circumstances. Interested parties may submit comments or identify their capabilities, but the government retains sole discretion in determining whether to compete the requirement.
Notice text
Floxuridine vials for injection for the NIH Clinical Center (CC)
- Product Service Code: Q509
- NAICS Code: 424210
- Place of Performance: Bethesda, MD 20892
POTS: 24-006053
Description
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.
The National Institutes of Health (NIH) intends to award a fixed price purchase order to: Cardinal Health, Inc. located at 7000 Cardinal Pl, Dublin, OH 43017 on a firm fixed price sole source award basis to provide 10 each vials of Floxuridine for injection.
The below items are required for this action:
Catalog Number Description Quantity
0143-9270-01 Floxuridine for Injection 10
This supply is needed for planned patient care at the National Institutes of Health, Clinical Center and is distributed in the United States only by the proposed vendor.
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.
Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to kristin.nagashima@nih.gov by the due date April 25, 2024 and time marked in this notice
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity